Post-doc – Therapeutic agents evaluation on lymphoma cells with a high frequency based analysis technique
Within this context, the MH2F team of LAAS-CNRS in close partnership with team 9 of CRCT is developing a new physical analysis technique, which could exhibit such abilities. It is based on the exploitation of microwave dielectric spectroscopy . The technique has been previously developed and validated for cells quantification and viability [2-3]. The core of the project is now to evaluate the effectiveness of therapeutic agents on lymphoma cells. Despite the efficiency of current treatments, some lymphomas are indeed still incurable because of the aggressiveness or the stage of the disease but also according to the patient. Being able to in vitro evaluate the efficiency of chemicals on patient cells presents therefore a pertinent interest toward personalized therapies.
More information : PD_LAAS_CRCT_2015